Medeon Biodesign, Inc. (TPEX:6499)
83.30
-0.70 (-0.83%)
At close: Mar 6, 2026
Medeon Biodesign Market Cap
Medeon Biodesign has a market cap or net worth of 7.68 billion as of March 6, 2026. Its market cap has increased by 110.05% in one year.
Market Cap
7.68B
Enterprise Value
6.95B
Revenue
381.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
83.30
Market Cap Chart
Since December 11, 2014, Medeon Biodesign's market cap has increased from 5.77B to 7.68B, an increase of 33.18%. That is a compound annual growth rate of 2.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 7.75B | -11.11% |
| Dec 31, 2025 | 8.72B | 138.60% |
| Dec 31, 2024 | 3.65B | -14.91% |
| Dec 29, 2023 | 4.29B | -15.67% |
| Dec 30, 2022 | 5.09B | -22.76% |
| Dec 30, 2021 | 6.59B | 80.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Visco Vision | 11.75B |
| Vizionfocus | 10.42B |
| Bioteque | 8.39B |
| Formosa Optical Technology | 6.01B |
| Pacific Hospital Supply | 5.93B |
| St.Shine Optical | 5.55B |
| SciVision Biotech | 5.06B |
| Bionime | 4.15B |